𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Peripheral blood monocyte subsets predict antiviral response in chronic hepatitis C

✍ Scribed by Y. Rodríguez-Muñoz; S. Martín-Vílchez; R. López-Rodríguez; Á. Hernández-Bartolomé; M. Trapero-Marugán; M. J. Borque; R. Moreno-Otero; P. Sanz-Cameno


Book ID
108606426
Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
447 KB
Volume
34
Category
Article
ISSN
0269-2813

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Peripheral-blood mononuclear cell respon
✍ Haim Schupper; Paul Hayashi; James Scheffel; Sherri Acettuno; Teresa Paglieroni; 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 614 KB

Peripheral blood mononuclear cell proliferative responses in uitro to recombinant yeast or Escherichia coli hepatitis C virus fusion proteins were evaluated in 20 patients with chronic hepatitis C who were reactive for antibody to hepatitis C virus (on enzyme immunoassay, version 2.0, and a four-ant

Early Hepatitis C virus–RNA responses pr
✍ William M. Lee; K. Rajender Reddy; Myron J. Tong; Martin Black; Dirk J. van Leeu 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 2 views

In previous studies employing interferons (IFNs) in the treatment of chronic hepatitis C, there have been few reliable predictors of sustained responses. We retrospectively evaluated the predictive value of hepatitis C virus (HCV)-RNA measurements in the first few months during consensus interferon

Hepatitis C virus RNA in peripheral bloo
✍ T Chang; K Young; Y Yang; H Lei; H Wu 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB 👁 2 views

Hepatitis C virus (HCV) can infect peripheral blood mately 10 kb. 2 Acute posttransfusion hepatitis C mononuclear cells (PBMC) of patients with chronic HCV (PTHC) is followed by chronic hepatitis in about 50% infection. No data are available on PBMC testing for of the cases. Chronic hepatitis may al

Caspase activation is required for antiv
✍ Xandra Volkmann; Markus Cornberg; Heiner Wedemeyer; Frank Lehner; Michael P. Man 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 239 KB 👁 1 views

Only half of patients with chronic hepatitis C virus (HCV) infection and genotype-1 show a sustained antiviral response to the current antiviral therapy. The reason this treatment fails is unclear, and no reliable marker exists that predicts the treatment outcome. In the present study, we investigat

Haplotype-tagging RANTES gene variants i
✍ Hermann E. Wasmuth; Alexa Werth; Tobias Mueller; Thomas Berg; Christoph G. Dietr 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB

The response to antiviral therapy for chronic hepatitis C virus (HCV) is complex and is determined by both environmental and genetic factors. Recently, interacting gene polymorphisms of the chemokine RANTES have been shown to affect HIV disease progression. Our aim was to assess if these RANTES vari